Abstract
We analyzed the influence of packed red bloodcell (PRBC) transfusions on the prognosis of 163patients with gastric adenocarcinoma undergoing subtotalgastrectomy with a curative intention. Over a period of 15 years, our department admitted 505patients with gastric adenocarcinoma, with curativesubtotal gastrectomy being performed in 167 cases. Meanage was 62.2 years (range: 30–87); there was apredominance of males (104 cases; 63.8%). Excluding the fourpatients who died in the immediate postoperative period(first 30 days), the remaining 163 were reviewed twiceyearly in our department until either they died or the study ended. Follow-up averaged49.5 months, with a median of 36 months. Sixty-nine(42.3%) of the 163 patients received transfusions ofPRBC. On correlating the variables with the transfusion, we found a statistical significance onlybetween the rate of transfusion and patient age over 63years (P < 0.01), with an evolution time of less thanthree months (P < 0.05) and in tumors of >4 cm (P< 0.05). The five-year survival rate of thenontransfusion patients was 56.9% and of the transfusionpatients 40%, with statistically significant differences(P = 0.0132). On studying patients according to tumor stage, we found that blood transfusion had astatistically significant influence on prognosis only inpatients with tumor stage III (P = 0.0051). In theunivariate analysis of the remaining variablescollected, the existence of abdominal tumor (P = 0.0307),tumor size (P = 0.00001), degree of involvement of thegastric wall (P = 0.00001), lymph node involvement (P =0.00001) and tumor stage (P = 0.00001) revealed a statistically significant influence onprognosis. If we apply Cox's regression model to thevariables that in the univariate analysis had astatistically significant influence on prognosis, wefound that only tumor size and stage were independentpredictors of survival. In our experience, PRBCtransfusion does not influence the long-term survival ofpatients with resected gastric adenocarcinoma.
Similar content being viewed by others
REFERENCES
Burrows L, Tartter P: Effect of blood transfusions on colonic malignancy recurrente rate. Lancet 2:662, 1982
Blumberg N, Heal JM, Murphy P, Agarwal MH, Chuang C: Association between transfusion of whole blood and recurrente of cancer. Br Med J 293:530-533, 1986
Blumberg N, Chuang-Stein C, Heal JM: The relationship of blood transfusion, tumor staging, and cancer recurrente Transfusion. 30:291-294, 1990
Nielsen HJ: Detrimental effects of perioperative blood transfusion. Br J Surg 82:582-587, 1995
Houblers JGA, Busch OR, Van de Watering LMG, Marquet RL, Brand A, Jeekel H, Van de Velde CJH: Blood transfusion in cancer surgery: A consensus statement. Eur J Surg 161:307-314, 1995
Kampschöer GHM, Maruyama K, Sasako M, Kinoshita T, Van de Velde CJH: The effects of blood transfusion on the prognosis of patients with gastric cancer. W J Surg 13:637-643, 1989
Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y: Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer 66:2331-2335, 1990
Kaneda M, Horimi T, Ninomlya M, Nagae S, Mukal K, Takeda Y, Shimoyama H, Chohno S, Okabayashi T, Kagawa S, Orita K: Adverse effect of blood transfusions on survival of patients with gastric cancer. Transfusion 27:375-377, 1987
Fong Y, Karpech M, Mayer K, Brennan MF: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167:256-260, 1994
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
Christensen E: Multivariate survival analysis using Cox's regression model. Hepatology 7:1346-1358, 1987
Lenhard V, Mytilineos J, Opelz G: Immunomodulation after blood transfusion in rats. transplant Proc 19:1428, 1987
Ross WB, Beavis MJ, Salaman JR: Effects of blood transfusions on T-lymphocytes subpopulation in the Spregue-Dawley rat. Surg Res Commun 4:183-186, 1988
Gascon P, Zoumbos NC, Young NS: Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 100:173-177, 1984
Blumberg N, Triulzi DJ, Heal JM: Transfusion-induced immunomodulation and its clinical consequences. Transfus Med Rev 4:24-35, 1990
Kaplan J, Sarnaik S, Gitlin J, Lusher J: Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308-310, 1984
Ritz J: The role of natural killer cells in immune surveillance. N Engl J Med 320:1748-1749, 1989
Bodmer W: T-cell immune responses to cancer-a new look. Hum Immunol 30:259-261, 1991
Foster RS Jr, Costanza MC, Foster JC, Wanner MC, Foster CB: Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 55:1195-1201, 1985
Blumberg N, Heal J, Chuang C, Murphy P, Agarwal M: Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 207:410-415, 1988
Chung M, Steinmetz OK, Gordon PH: Peroperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 80:427-432, 1993
Busch ORC, Hop WCJ, Marquet RL, Jeekel J: Blood transfusions and local tumor recurrence in colorectal cancer: Evidence of a non-causal relationship. Ann Surg 220:791-797, 1994
Crowson MC, Hallisey MT, Kiff RS: Blood transfusion in colorrectal cancer. Br J Surg 76:522-523, 1989
Vamvakas E, Moore SB: Perioperative blood transfusion and colorectal cancer recurrence. A qualitative statistical overview and meta-analysis. Transfusion 33:754-765, 1993
Maeta M, Shimizu N, Oka A, Kondo A, Yamashiro H, Tsujitani S, Kegchi M, Kaibara N: Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 55:149-153, 1994
Houbiers JGA, Brand A, Watering LMG, Van de Verwey PJM: Randomised controlled trial comparing the transfusion of leucocyte-depleted or buffy coat-depleted blood in surgery for colorectal cancer. Lancet 344:573-578, 1994
Jensen LS, Heiss MM, Mempel W, Jauch KW, Schildberg FW, Houbiers JGA, Watering LMG van de, Verwey PJM: Leucocyte-depleted or buffy coat-depleted blood in surgery for colorectal cancer. Lancet 344:1429-1430, 1994
Marsh J, Donnan PT, Hamer-Hodges DW: Association between transfusion with plasma and the recurrence of colorectal cancer. Br J Surg 77:623-626, 1990
Rights and permissions
About this article
Cite this article
Sanchez-Bueno, F., Garcia-Marcilla, J.A., Perez-Abad, J.M. et al. Does Perioperative Blood Transfusion Influence Long-Term Prognosis of Gastric Cancer?. Dig Dis Sci 42, 2072–2076 (1997). https://doi.org/10.1023/A:1018818517811
Issue Date:
DOI: https://doi.org/10.1023/A:1018818517811